A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses

OBJECTIVE: Glioblastoma (GBM) is the most common primary malignant brain tumor regulated by numerous genes, with poor survival outcomes and unsatisfactory response to therapy. Therefore, a robust, multi-gene signature-derived model is required to predict the prognosis and treatment response in GBM....

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Mianfu, Cai, Juan, Yuan, Ye, Shi, Yu, Wu, Hong, Liu, Qing, Yao, Yueliang, Chen, Lu, Dang, Weiqi, Zhang, Xiang, Xiao, Jingfang, Yang, Kaidi, He, Zhicheng, Yao, Xiaohong, Cui, Yonghong, Zhang, Xia, Bian, Xiuwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743613/
https://www.ncbi.nlm.nih.gov/pubmed/31565488
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743613/
https://www.ncbi.nlm.nih.gov/pubmed/31565488
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0277

Ejemplares similares